missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ PRMT7 Recombinant Rabbit Monoclonal Antibody (K01_1X12)

Description
PRMT7 Recombinant Monoclonal Antibody for Western Blot
Arginine methylation is an irreversible post translational modification which has been implicated in RNA processing and trafficking, receptor-mediated signaling, and transcription. At least three types of PRMT enzymes have been identified in mammalian cells. These enzymes have been shown to have essential regulatory functions by methylation of key proteins in several fundamental areas. These proteins include nuclear proteins, IL enhancer binding factor, nuclear factors, cell cycle proteins, signal transduction proteins, apoptosis proteins, and viral proteins. The mammalian PRMT family currently consists of 7 members that share two large domains of homology. Outside of these domains, epitopes were identified and antibodies against all 7 PRMT members have been developed.
Specifications
Specifications
| Antigen | PRMT7 |
| Applications | Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | K01_1X12 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 50mM tris glycine with 150mM NaCl, 0.05% BSA, 40% glycerol and 0.01% sodium azide; pH 7.4 |
| Gene | PRMT7 |
| Gene Accession No. | Q5U4E8, Q922X9, Q9NVM4 |
| Gene Alias | [Myelin basic protein]-arginine N-methyltransferase PRMT7; 4933402B05Rik; BC006705; FLJ10640; Histone-arginine N-methyltransferase PRMT7; KIAA1933; myelin basic protein-arginine N-methyltransferase; PRMT7; PRMT-7; protein arginine methyltransferase 7; protein arginine N-methyltransferase 7; RGD1304869 |
| Vedi altri risultati |
Titolo del prodotto
Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.
Individuate un'opportunità di miglioramento?